Emphysema and Interstitial Lung Disease in Systemic Sclerosis-related Pulmonary Hypertension

Overview

Journal Respir Med

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2023 Jun 19

PMID 37336329

Authors

Jasmine Vakhshoorzadeh

Justin K Lui

Ruchika A Sangani

Marcin A Trojanowski

Andreea M Bujor

Michael P LaValley

Elizabeth S Klings

Affiliations

Soon will be listed here.

References

Ariani A, Silva M, Bravi E, Parisi S, Saracco M, DE Gennaro F . Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis. RMD Open. 2019; 5(1):e000820. PMC: 6397433. DOI: 10.1136/rmdopen-2018-000820. View

Le Pavec J, Girgis R, Lechtzin N, Mathai S, Launay D, Hummers L . Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum. 2011; 63(8):2456-64. DOI: 10.1002/art.30423. View

Hoa S, Bernatsky S, Steele R, Baron M, Hudson M . Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis. Rheumatology (Oxford). 2019; 59(5):1108-1117. PMC: 7850061. DOI: 10.1093/rheumatology/kez407. View

Magnussen C, Ojeda F, Rzayeva N, Zeller T, Sinning C, Pfeiffer N . FEV1 and FVC predict all-cause mortality independent of cardiac function - Results from the population-based Gutenberg Health Study. Int J Cardiol. 2017; 234:64-68. DOI: 10.1016/j.ijcard.2017.02.012. View

Sangani R, Lui J, Gillmeyer K, Trojanowski M, Bujor A, LaValley M . Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity. Pulm Circ. 2022; 12(4):e12117. PMC: 9535436. DOI: 10.1002/pul2.12117. View

Mathai S, Hummers L, Champion H, Wigley F, Zaiman A, Hassoun P . Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum. 2009; 60(2):569-77. DOI: 10.1002/art.24267. View

Chauvelot L, Gamondes D, Berthiller J, Nieves A, Renard S, Catella-Chatron J . Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary.... Arthritis Rheumatol. 2020; 73(2):295-304. DOI: 10.1002/art.41512. View

Chetta A, Marangio E, Olivieri D . Pulmonary function testing in interstitial lung diseases. Respiration. 2004; 71(3):209-13. DOI: 10.1159/000077416. View

Koo B, Park K, Lee H, Kim H, Ahn H, Yim S . Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther. 2021; 23(1):100. PMC: 8022385. DOI: 10.1186/s13075-021-02494-y. View

10.

Steen V, Medsger T . Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007; 66(7):940-4. PMC: 1955114. DOI: 10.1136/ard.2006.066068. View